Imiloxan
Imiloxan (RS 21361) is a potent and selective alpha 2B-adrenoceptor antagonist. Imiloxan produces a dose-related reversal of Guanoxabenz -induced maximal mydriasis in male rats. Imiloxan has the potential for acute kidney injury research[1][2][3].
Product Specifications
CAS Number
81167-16-0
Product Name Alternative
RS 21361 (free base)
UNSPSC
12352005
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/imiloxan.html
Solubility
10 mM in DMSO
Smiles
CCN1C=CN=C1CC2OC3=CC=CC=C3OC2
Molecular Formula
C14H16N2O2
Molecular Weight
244.29
References & Citations
[1]A D Michel, et al. Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist. Br J Pharmacol. 1990 Mar;99 (3) :560-4. |[2]Takaomi Shimokawa, et al. Renoprotective effect of yohimbine on ischaemia/reperfusion-induced acute kidney injury through α2C-adrenoceptors in rats. Eur J Pharmacol. 2016 Jun 15;781:36-44. |[3]Berridge TL, et al. alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system. Br J Pharmacol. 1983 Mar;78 (3) :507-15.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
17155126 3x 1.0µg DNA
CWF19L2 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
GTR10432809 96 Well
Sheep Cytosolic phospholipase A2 zeta (PLA2G4F) ELISA kit
Sign In for Pricing
View Details